Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wolfe Research Initiates Coverage On ShockWave Medical with Outperform Rating, Announces Price Target of $255

Wolfe Research analyst Mike Polark initiates coverage on ShockWave Medical (NASDAQ:SWAV) with a Outperform rating and announces Price Target of $255.
byBenzinga Newsdesk
April 6, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Wolfe Research analyst Mike Polark initiates coverage on ShockWave Medical (NASDAQ:SWAV) with a Outperform rating and announces Price Target of $255.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0